AMBER KOERNER: Open Payments
NPI 1225733892 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 21 payments from 9 companies in 2025. Trend: 2023 $107 · 2024 $397 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Lilly USA, LLC | 4 | $91 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| Amgen Inc. | 4 | $67 |
| SHIELD THERAPEUTICS INC | 1 | $28 |
| Exact Sciences Corporation | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $17 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, KISUNLA, REPATHA, EVENITY, ACCRUFER, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
